Complicated Osteoporosis in Progeroid Syndrome: Treatment With Teriparatide

Hennekam, 2006, Hutchinson-Gilford progeria syndrome: review of the phenotype, Am J Med Genet A, 140, 2603, 10.1002/ajmg.a.31346 Gordon, 2007, Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development, Pediatrics, 120, 824, 10.1542/peds.2007-1357 Puente, 2011, Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome, Am J Hum Genet, 88, 650, 10.1016/j.ajhg.2011.04.010 Zini, 2008, Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts, J Cell Biochem, 105, 34, 10.1002/jcb.21796 Merideth, 2008, Phenotype and course of Hutchinson-Gilford progeria syndrome, N Engl J Med, 358, 592, 10.1056/NEJMoa0706898 Merideth, 2008, Hutchinson-Gilford progeria syndrome, N Engl J Med, 358, 2410, 10.1056/NEJMoa0706898 Ortiz, 2008, Hutchinson-Gilford progeria syndrome, N Engl J Med, 358, 2409, 10.1056/NEJMc086092 Varela, 2008, Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging, Nat Med, 14, 767, 10.1038/nm1786 Fleisch, 1998, Bisphosphonates: mechanisms of action, Endocr Rev, 19, 80, 10.1210/er.19.1.80 Hishiya, 2004, Progeroid syndrome as a model for impaired bone formation in senile osteoporosis, J Bone Miner Metab, 22, 399, 10.1007/s00774-004-0517-z